Ellingson Alan Wayne

CFO Alan Wayne Ellingson sold 44.7K shares of DKNG at $44.90 on 2025-08-19 (total $2.0M); all 4 prior DKNG sales were well-timed with negative 90d returns.

Ellingson sold 44,693 shares, reducing his holdings by 25.9%, continuing a pattern of open-market DKNG dispositions. His prior 4 sales at this ticker (2025-02-25/26) all posted negative 90-day returns (-20.1%, -18.0%, -17.5%, -16.9%), indicating consistent forward-looking accuracy in timing at the DKNG ticker. His cross-ticker track record also shows a 100.00% well-timed rate across 4 prior sells with an average 90d return of -18.1%, confirming a disciplined execution pattern. The current stock price of $46.09 is -13.8% from the 52-week high of $53.49; the 30-day return is +3.4% while the 90-day return is +31.4%, meaning the stock has strengthened since the August transaction. The company's fundamentals show $1.5B in quarterly revenue and positive $157.9M net income, but full-year net income was negative, creating a mixed fundamental backdrop against an otherwise strong quarter.

CFO Alan Wayne Ellingson sells 164,542 shares of DKNG for $6,984,333.53, reducing stake by 48.7%

Alan Wayne Ellingson, Chief Financial Officer of DraftKings, executed 4 separate sales totaling 164,542 shares for $6,984,333.53 on 2025-02-25 and 2025-02-26, at prices ranging from $42.21 to $43.91 with a blended average of $42.45. This transaction reduced his holdings from 338,096 shares to 173,554 shares, representing a 48.7% reduction in his position. The timing occurs as DraftKings stock trades at $43.36 (near the top of its recent trading range and -18.9% below its 52-week high of $53.49), while the company reported a net loss of $293.7M on $1.1B quarterly revenue. The substantial size of this divestment—nearly half of his pre-transaction holdings liquidated over two trading days—warrants scrutiny given the company's current unprofitability, though the volume and execution prices suggest deliberate rather than forced action.